Christine Matthews - 06 Jun 2022 Form 4 Insider Report for Zosano Pharma Corp

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 06 Jun 2022
Net transaction value: -$58.22
SEC form: 4
Accepted by SEC: 07 Jun 2022, 19:39:15 UTC
Prior SEC filing: 01 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Christine Matthews

Filing notes and source

Key filing fact

Christine Matthews filed Form 4 for Zosano Pharma Corp on 07 Jun 2022.

Key facts

This page summarizes Christine Matthews's Form 4 filing for Zosano Pharma Corp.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2022, 19:39.

Change

Previous filing in this sequence was filed on 01 Apr 2022.
Current net transaction value: -$58.22.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZSAN transaction

Common Stock

Sale

Transaction value: -$58.22
Shares: -82
Change %: -1.9%
Price: $0.7100^*
Shares after: 4,183
Date: 06 Jun 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.

Footnote F2

Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.